跳至主要内容
临床试验/NCT01616719
NCT01616719撤回不适用

Evaluation of DTRAX Graft in Patients With Cervical Degenerative Disc Disease

Providence Medical Technology, Inc.4 个研究点 分布在 1 个国家开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
4
主要终点
Gather clinical outcome data on DTRAX Graft.

研究概览

简要总结

DTRAX Graft is used to relieve nerve pressure in the neck in order to provide relief for Cervical Degenerative Disc Disease. This study is being conducted to determine the effectiveness of the graft, and to find out whether or not it provides better results or faster healing than traditional ways of performing surgery for Cervical Degenerative Disc Disease.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
35 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject diagnosed with DDD in C3-C7, defined as follows:
  • Radiographically (at least one):
  • degenerated disc on MRI;
  • decreased disc height on plain film, CT or MRI; and/or
  • disc herniation, as demonstrated by CT or MRI.
  • Clinically: radicular symptoms (at least one):
  • arm/shoulder pain;
  • decreased reflexes;
  • decreased strength; and/or
  • decreased sensation.
  • Subject has single-level disease, OR multi-level disease demonstrated radiographically, and confirmed to be symptomatic by one of the following methods:
  • Selective nerve root block, OR
  • Distinctive clinical examination.
  • Subject has dynamic stenosis relieved by traction and made worse by a Spurlings maneuver.
  • Subject is 35-80 years of age, inclusive.
  • Subject is unresponsive to 6 weeks conservative, nonoperative treatment, or has the presence of progressive symptoms or signs of nerve root compression in face of combined nonoperative management.
  • Preoperative NDI score of ≥
  • Preoperative neck pain and arm pain score of ≥ 6 on Neck and Arm Pain Scales.
  • Patient is a male or non-pregnant, non-lactating female.
  • Female patients of child-bearing potential, including those who have had a tubal ligation, but excluding those who have not experienced a menstrual period for at least two years, must have a negative urine pregnancy test at Screening.
  • Patient must voluntarily provide written, informed consent.
  • Subject is able to meet the proposed follow-up schedule.
  • Subject is able to follow the postoperative management program.

排除标准

  • Subject has severe osteopenia, osteoporosis, osteomalacia, spinal metastases, or metabolic bone disease OR the level of BMD is a T score of -2.5 or below OR patient has sustained a vertebral compression or nontraumatic hip or wrist fracture.
  • Subject has overt or active spinal and/or systemic infection.
  • Subject has spondylolisthesis ≥ 3.5mm or rotator subluxation.
  • Subject has cervical myelopathy.
  • Subject has a chronic pain syndrome.
  • Subject has radicular findings with major motor impairment.
  • Subject has a condition that requires postoperative medications that interfere with fusion or the stability of the implant, such as steroids.
  • Subject is mentally incompetent.
  • Subject is a prisoner.
  • Subject is pregnant.
  • Subject abuses alcohol or drugs.
  • Subject has a cervical spinal condition other than symptomatic cervical disc disease requiring surgical treatment at the involved level.
  • Subject has insulin dependent diabetes.
  • Subject has chronic or acute renal failure or prior history of renal disease.
  • Subject has fever at the time of surgery, defined as > 38.5 degrees C.
  • Subject has documented allergy or intolerance to stainless steel, titanium, or a titanium alloy.
  • Subject has received drugs which may interfere with bone metabolism within two weeks prior to the planned date of DTRAX surgery.
  • Subject has history of an endocrine or metabolic disorder known to affect osteogenesis .
  • Subject has had treatment with an investigational therapy within 28 days prior to DTRAX surgery or such treatment is planned during the 16 weeks following implantation of DTRAX Graft.
  • Subject is involved in spinal litigation or Workmen's Compensation claim.
  • Subject is obese, defined as body mass index (BMI) >
  • Patient has psychiatric history, head injury or any other condition, which, in the Investigator's opinion, would prevent the patient from complying with postoperative follow-up visits.

结局指标

主要结局

Gather clinical outcome data on DTRAX Graft.

时间窗: Baseline throughout 12 months post-operatively

Clinical outcome data will be collected using the Neck Disability Index (NDI), Visual Analogue Scale (VAS), and a quality of life questionnaire.

次要结局

  • Safety information will be evaluated by collecting the type, frequency, severity, device, and procedure-relatedness of adverse events.(Baseline throughout 12 months post-operatively)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验